Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    CAS 144702-27-2 manufacturers and suppliers on PharmaCompass

    Client Email Product

    CAS 144702-27-2

    Manufacturers/Suppliers

    MARKET PLACE

    PharmaCompass
    CAS 144702-27-2
    Also known as: 144702-27-2, A8m0gxg1xv, 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzonitrile, (1,1'-biphenyl)-2-carbonitrile, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1h-benzimidazol)-1'-yl)methyl)-, 4'-((4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1-yl)methyl)biphenyl-2-carbonitrile, Telmisartan impurity g
    Molecular Formula
    C33H29N5
    Molecular Weight
    495.6  g/mol
    InChI Key
    XIEVZYAEXURSHX-UHFFFAOYSA-N
    FDA UNII
    A8M0GXG1XV
    1 2D Structure

    CAS 144702-27-2

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzonitrile
    2.1.2 InChI
    InChI=1S/C33H29N5/c1-4-9-31-36-32-22(2)18-26(33-35-28-12-7-8-13-29(28)37(33)3)19-30(32)38(31)21-23-14-16-24(17-15-23)27-11-6-5-10-25(27)20-34/h5-8,10-19H,4,9,21H2,1-3H3
    2.1.3 InChI Key
    XIEVZYAEXURSHX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C#N)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
    2.2 Other Identifiers
    2.2.1 UNII
    A8M0GXG1XV
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 144702-27-2

    2. A8m0gxg1xv

    3. 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzonitrile

    4. (1,1'-biphenyl)-2-carbonitrile, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1h-benzimidazol)-1'-yl)methyl)-

    5. 4'-((4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1-yl)methyl)biphenyl-2-carbonitrile

    6. Telmisartan Impurity G

    7. Unii-a8m0gxg1xv

    8. Telmisartan Impurity G [ep]

    9. 4'-[[4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1-yl]methyl]biphenyl-2-carbonitrile

    10. Telmisartan Ep Impurity G

    11. Schembl2020774

    12. Dtxsid20162790

    13. Zinc71973211

    14. 2-descarboxy-2-cyano Telmisartan-[d3]

    15. Db-050162

    16. Ft-0665981

    17. Telmisartan Impurity G [ep Impurity]

    18. Imidazo[1,2-a]pyridine-3-carboxaldehyde,oxime

    19. A1-01721

    20. Q27273773

    21. 4'-(1,4'-dimethyl-2'-propyl-2,6'-bi[1h-benzoimidazole]-1'-ylmethyl)biphenyl-2-carbonitrile

    22. 4'-[(1,4'-dimethyl-2'-propyl [2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carbonitrile

    23. 4'-[[2-n-propyl-4-methyl-6-(1-methyl-benzimidazol-2-yl)-1hbenzimidazol-1-yl]-methyl]-2-cyano-biphenyl4'-[[2-n-propyl-4-methyl-6-(1-2methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-2-cyano-biphenyl

    24. 4'-[[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-2-cyano-biphenyl

    25. 4?-[[4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1-yl]methyl][1,1?-biphenyl]-2-carbonitrile

    2.4 Create Date
    2006-12-11
    3 Chemical and Physical Properties
    Molecular Weight 495.6 g/mol
    Molecular Formula C33H29N5
    XLogP37.1
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count6
    Exact Mass495.24229595 g/mol
    Monoisotopic Mass495.24229595 g/mol
    Topological Polar Surface Area59.4 Ų
    Heavy Atom Count38
    Formal Charge0
    Complexity829
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    ListList of Suppliers
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    Jiangsu Zhongbang Pharmaceutical Co...

    Contact Supplier
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    4-Methyl-2-n-Propyl-1H-Benzimidazole-6-Carboxylic Acid

    PDF Supplier PDF
    URL Supplier Web Content
    152628-03-0
    Telmisartan
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Jiangsu Zhongbang Pharmaceutical Co...

    Contact Supplier
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 4

    PDF Supplier PDF
    URL Supplier Web Content
    114772-34-8
    Telmisartan
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Jiangsu Zhongbang Pharmaceutical Co...

    Contact Supplier
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    2-n-Propyl-4-Methyl-6-(1-Methyl Benzimidazole-2-yl)Benz...

    PDF Supplier PDF
    URL Supplier Web Content
    152628-02-9
    Telmisartan
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Jiangsu Zhongbang Pharmaceutical Co...

    Contact Supplier
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Methyl 4’-Bromomethyl Biphenyl-2-Carboxylate

    PDF Supplier PDF
    URL Supplier Web Content
    114772-38-2
    Telmisartan
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...
    Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search